Kuczkowski Krzysztof M, Chandra Susilo
Department of Anesthesiology, UCSD Medical Center, San Diego, CA 92103-8770, USA.
J Anesth. 2008;22(1):55-8. doi: 10.1007/s00540-007-0569-z. Epub 2008 Feb 27.
The purpose of this study was to assess maternal satisfaction with single-dose spinal analgesia for the management of obstetric pain in Indonesian women. The investigation included 62 laboring women with single pregnancy at term, with 45 primigravidas and 17 multigravidas. The participants' ages ranged from 15 to 29 years. All participants were screened for physical health and were classified as healthy according to the American Society of Anesthesiologists classification system. All 62 parturients received single-dose spinal anesthesia with a 27-gauge pencil-point needle at either the L3-4 or L4-5 intervertebral interspace, with a combination of bupivacaine, 2.5 mg; morphine, 0.25 mg; and clonidine, 45 microg. Maternal satisfaction, duration of pain relief, and side effects were studied. The overall maternal satisfaction with the single-dose spinal technique for labor analgesia in our study group was high, with 50 patients (81%) being very satisfied, and 7 patients (11%) being satisfied with the quality of labor analgesia. Forty-nine patients (79%) stated that they would select single-dose spinal analgesia for pain control in labor in the future. Our study was the first one in Indonesia to assess maternal satisfaction with single-dose spinal analgesia for labor pain. We concluded that single-dose spinal analgesia with a combination of bupivacaine, morphine, and clonidine provided effective labor pain control for Indonesian women, and maternal satisfaction with this technique was very high. This technique is very cost-effective and should be recommended for routine obstetric pain control in Indonesia and other developing countries.
本研究的目的是评估印度尼西亚妇女对单剂量脊髓镇痛用于产科疼痛管理的满意度。该调查纳入了62名单胎足月分娩的妇女，其中45名为初产妇，17名为经产妇。参与者的年龄在15至29岁之间。所有参与者均接受了身体健康筛查，并根据美国麻醉医师协会分类系统被归类为健康。所有62名产妇均使用27号铅笔头针在L3 - 4或L4 - 5椎间隙接受了单剂量脊髓麻醉，药物组合为布比卡因2.5毫克、吗啡0.25毫克和可乐定45微克。对产妇满意度、疼痛缓解持续时间和副作用进行了研究。在我们的研究组中，产妇对单剂量脊髓技术用于分娩镇痛的总体满意度较高，50名患者（81%）非常满意，7名患者（11%）对分娩镇痛质量满意。49名患者（79%）表示她们未来会选择单剂量脊髓镇痛来控制分娩疼痛。我们的研究是印度尼西亚首个评估产妇对单剂量脊髓镇痛用于分娩疼痛满意度的研究。我们得出结论，布比卡因、吗啡和可乐定联合使用的单剂量脊髓镇痛为印度尼西亚妇女提供了有效的分娩疼痛控制，产妇对该技术的满意度非常高。该技术性价比很高，应推荐用于印度尼西亚和其他发展中国家的常规产科疼痛控制。
